NYSE:BIOLife Sciences
Is Bio-Rad Laboratories (BIO) Starting To Look Attractive After Prolonged Share Price Weakness?
Wondering if Bio-Rad Laboratories at around US$305 a share is starting to look like value, or if the recent price action is a warning sign you should not ignore?
The stock has been volatile, with a 5.2% decline over the last week, a 1.4% gain over the past month, and longer term returns of a 13.4% decline over 1 year, 35.9% decline over 3 years, and 46.1% decline over 5 years.
These moves sit against a backdrop of ongoing interest in life sciences and diagnostics. In this space, investors...